• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MAGELLAN DIAGNOSTICS, INC. LEADCARE II BLOOD LEAD TEST SYSTEM; LEADCARE II ANALYZER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MAGELLAN DIAGNOSTICS, INC. LEADCARE II BLOOD LEAD TEST SYSTEM; LEADCARE II ANALYZER Back to Search Results
Model Number 70-6529
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 10/24/2014
Event Type  malfunction  
Manufacturer Narrative
Mdr 1218996-2018-00022 addendum: user facility contacted magellan's product support team to report suppressed blood lead results on the leadcare ii blood lead analyzer when compared to reference lab results.Visual inspection of the returned leadcare ii analyzer confirmed corrosion on the sensor pins.Corrosion of the sensor pins typically occurs when there is overexposure of the analyzer pins to the assay's acidic treatment reagent.This occurs when used test sensors are not removed immediately after testing (per instrument instructions) or when too much sample is added to the test sensor.Also, periodic testing with blood lead qc controls is used to monitor analyzer performance after investigation it was determined that the user did not perform qc as intended.Magellan provided the customer with a new instrument, and additional training.No reported harm or injuries occurred as a result of this issue.Note: late filing is part of magellan diagnostics, inc.Response to fda's 483 issued on (b)(6) 2017.(b)(4).Patient sample results for lcu vs (b)(6) (in ug/dl) were all filled under one mdr.We will now be submitting separate mdrs for each individual patient result.Results: (lcu vs (b)(6)).9.9 vs15.0 [1218996-2019-00043]; 18.1 vs 21.0 [1218996-2019-00044]; 18.1 vs 23.0 [1218996-2019-00045].Customer complaint: (b)(4).
 
Event Description
Mdr 1218996-2018-00022 addendum: user facility contacted magellan's product support team to report suppressed blood lead results on the leadcare ii blood lead analyzer when compared to reference lab results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LEADCARE II BLOOD LEAD TEST SYSTEM
Type of Device
LEADCARE II ANALYZER
Manufacturer (Section D)
MAGELLAN DIAGNOSTICS, INC.
101 billerica ave.
building 4
n. billerica MA 01862
Manufacturer (Section G)
MAGELLAN DIAGNOSTICS, INC.
101 billerica ave
building 4
n. billerica MA 01862
Manufacturer Contact
ivy margaret thiong'o
101 billerica ave
building 4
n. billerica, MA 01862
9783135480
MDR Report Key9356619
MDR Text Key220627808
Report Number1218996-2019-00045
Device Sequence Number1
Product Code DOF
UDI-Device Identifier00850355006017
UDI-Public00850355006017
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K052549
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 11/21/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/21/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number70-6529
Device Catalogue Number70-6529
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/05/2014
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/24/2014
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/28/2014
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
-
-